FREDUNBSEFREDUN PHARMACEUTICALS LLowNeutral
Announced Fri, 23 Oct, 2026 · 18:30 IST

44,000 equity shares allotted on warrant conversion

Warrants ConvertedFund Raising View source PDFExplain this filing

FREDUN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.3%Reaction day
₹1374.00
prior close
₹1368.40
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-0.7% vs market
Pharmaceuticals peers, median of 174sector+1.2%-1.5% vs sector

On the reaction day the stock moved 0.7 pts less than Nifty Microcap 250 and 1.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.2
10m
-1.2
15m
-0.2
30m
-0.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.3+0.4-0.7+1.2-1.5
Next day
+6.0+2.1+3.8+3.1+2.9
2d
+7.2pendingpending+4.7+2.5
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 174Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

On 23 October 2026, the board allotted 44,000 fully paid equity shares of Rs 10 each to three non-promoter investors after conversion of 14,667 warrants. The warrants were issued in December 2025 at Rs 1,250 each. Following the 1:2 bonus issue, the warrant entitlement and exercise price were adjusted. The full balance was paid, and no warrants remain pending conversion.

Likely market impact

The 44,000 new shares raise the share count, and the company receives the remaining warrant payment. They rank equally with existing shares.